Navigation Links
Ameritox(R) CMO Elected Chairman of the American College of Physician Executives Board
Date:6/15/2009

BALTIMORE, June 15 /PRNewswire/ -- Harry Leider, M.D., MBA, FACPE, Ameritox's Senior Vice President and Chief Medical Officer, has been elected as President and Chairman of the Board for the American College of Physician Executives (ACPE), a national organization consisting of more than 10,000 physician leaders.

Dr. Leider became an ACPE member 20 years ago. He served as a core faculty member within the College for 13 years teaching courses on improving the quality of healthcare. He was elected to the board five years ago and has previously served as the organization's secretary-treasurer and vice-president.

"I look forward to working with the board to involve the ACPE more in healthcare reform, and in improving the quality of healthcare and enhancing patient safety, two of my personal passions," said Dr. Leider.

"The College always seems to elect the best person, with the best skills, at the right moment in time," says Barry Silbaugh, Chief Executive Officer of the ACPE. "Dr. Leider brings a vision of the strategic potential of the College and its members to effect change in health care, along with the leadership to make it a reality. He'll direct the College's initiatives to help the nation find solutions to healing a health system battered by the economy that also is not meeting the needs of consumers, businesses and health care professionals."

The ACPE is the oldest and longest standing organization in the United States to represent physicians who are leaders and executives in healthcare. It offers a number of training programs to physicians, including a certified executive program. The organization helps members learn to become physician leaders and highly effective executives through educational programming, networking opportunities, and partnerships with other healthcare organizations.

"Considering the incredible history of this organization and breadth of talent of its membership," says Dr. Leider, "I am incredibly honored, humbled and motivated to continue my work with the Board and our dynamic group of physician-executive members to make a significant impact on the health of all patients."

About Ameritox

Ameritox is the nation's leader in pain prescription drug monitoring, processing thousands of specimens everyday. Only Ameritox offers the Rx Guardian(SM) Report, the most thorough and personalized lab report available and the only report that uses a proprietary methodology to help physicians assess whether patients are taking their pain medication consistent with the dosage prescribed by their physicians. By comparing normalized values to expected prescription-specific ranges, Rx Guardian assists pain practitioners in protecting their patients by providing information to help them assess compliance based on prescription regimens. Rx Guardian also provides peace of mind to physicians and protection to their practices by providing data to help ensure that patients are taking pain medications as prescribed. Headquarters are located in Baltimore, MD, and laboratory facilities in Midland, TX. For additional information, please contact us by phone at 866-926-9264, by email at information.request@ameritox.com, or visit us at http://www.ameritox.com.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

    For more information, contact:
    Kristine Kelly
    Edelman
    212-704-8276
    kristine.kelly@edelman.com


'/>"/>
SOURCE Ameritox
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ameritox(R) Contracts With Aetna for Prescription Drug Monitoring Services
2. Brooke Franchise Corporation Announces Selected July Results
3. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
4. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
5. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
6. Montana Health Care Leader Elected Board Chair of National Association
7. Fry Construction Selected for High-Profile Medical Imaging Project
8. John B. Buse, MD, PhD of Chapel Hill, NC, Elected American Diabetes Association President, Medicine & Science
9. Meth Project Advertisements Selected for National Prevention Campaign
10. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
11. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... ... expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote ... recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound System. ... to RMT technology that delivers HD, dynamic, streaming ultrasound images and video to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... provided a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, ... were used to facilitate a recapitalization of MedPro led by Harren Equity Partners. ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Tranquility acoustic and privacy panel system. , The Tranquility privacy panel system ... a collaborative office environment. Tranquility panels help reduce noise and provide the visual ...
(Date:1/19/2017)... ... ... Tribble Insurance Agency, a family owned and operated firm offering asset protection ... to honor Chad Phillip Dermyer, a local police trooper who was shot and killed ... fellow officers were conducting routine stops of suspects when one of them, a violent ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... , January 19, 2017 ... ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... Published recently in a ... peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology: